KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Steris (STE) EBITDA (2018 - 2025)

Steris has reported EBITDA over the past 8 years, most recently at $273.2 million for Q4 2025.

  • Quarterly results put EBITDA at $273.2 million for Q4 2025, up 11.37% from a year ago — trailing twelve months through Dec 2025 was $1.0 billion (up 14.96% YoY), and the annual figure for FY2025 was $866.6 million, up 3.65%.
  • EBITDA for Q4 2025 was $273.2 million at Steris, up from $265.8 million in the prior quarter.
  • Over the last five years, EBITDA for STE hit a ceiling of $748.3 million in Q1 2023 and a floor of -$306.4 million in Q3 2022.
  • Median EBITDA over the past 5 years was $200.3 million (2021), compared with a mean of $187.8 million.
  • Peak annual rise in EBITDA hit 68697.62% in 2022, while the deepest fall reached 363.01% in 2022.
  • Steris' EBITDA stood at $202.9 million in 2021, then fell by 5.98% to $190.8 million in 2022, then grew by 18.69% to $226.5 million in 2023, then rose by 8.31% to $245.3 million in 2024, then grew by 11.37% to $273.2 million in 2025.
  • The last three reported values for EBITDA were $273.2 million (Q4 2025), $265.8 million (Q3 2025), and $246.0 million (Q2 2025) per Business Quant data.